ASAN FOUNDATION

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1989-06-23

Employees: 501

Market Cap: -

Website: https://ails.amc.seoul.kr

Clinical Trials

Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer

Phase 2

Conditions: Advanced or Recurrent Endometrial Cancer

Interventions: Drug: Doctaxel
Drug: Cisplatin

First Posted Date: 2011-10-28

Last Posted Date: 2017-05-31

Lead Sponsor: Asan Medical Center

Target Recruit Count: 59

Registration Number: NCT01461759

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Phase 3

Terminated

Conditions: Cervical Cancer

Interventions: Radiation: Radiation therapy
Drug: Carboplatin
Drug: Cisplatin

First Posted Date: 2011-10-28

Last Posted Date: 2017-05-31

Lead Sponsor: Asan Medical Center

Target Recruit Count: 21

Registration Number: NCT01461772

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Megace
Drug: DW-ES(B)

First Posted Date: 2011-10-21

Last Posted Date: 2014-06-25

Lead Sponsor: Asan Medical Center

Target Recruit Count: 56

Registration Number: NCT01456624

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Heart Rate Variability of Patients With Bipolar Disorder in Subsyndromal Depressive Phase

Completed

Conditions: Bipolar Disorder
Heart Rate Variability
Subsyndromal Depressive Phase

First Posted Date: 2011-10-19

Last Posted Date: 2011-10-19

Lead Sponsor: Asan Medical Center

Target Recruit Count: 92

Registration Number: NCT01455038

Locations: 🇰🇷
Asan medical center, Seoul, Korea, Republic of

Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients

Completed

Conditions: Cirrhosis of Liver

First Posted Date: 2011-10-05

Last Posted Date: 2019-02-01

Lead Sponsor: Asan Medical Center

Target Recruit Count: 423

Registration Number: NCT01446666

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258

Phase 2

Completed

Conditions: Gastrointestinal Stromal Tumors

Interventions: Drug: dovitinib

First Posted Date: 2011-09-27

Last Posted Date: 2020-01-18

Lead Sponsor: Asan Medical Center

Target Recruit Count: 30

Registration Number: NCT01440959

Locations: 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul,, Korea, Republic of

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin

Completed

Conditions: Overactive Bladder

Interventions: Drug: solifenacin 5mg, 10mg

First Posted Date: 2011-09-21

Last Posted Date: 2014-05-30

Lead Sponsor: Asan Medical Center

Target Recruit Count: 262

Registration Number: NCT01437670

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

EFficacy of Prophylactic Clip Application in Decrease of Immediate Postpolypectomy Bleeding and Delayed Postpolypectomy Bleeding After Colonoscopic Removal for a Large Pedunculated Polyps

Not Applicable

Completed

Conditions: Polyp of Large Intestine

Interventions: Procedure: prophylactic clip application

First Posted Date: 2011-09-21

Last Posted Date: 2020-02-26

Lead Sponsor: Asan Medical Center

Target Recruit Count: 137

Registration Number: NCT01437631

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia

Completed

Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive

First Posted Date: 2011-09-20

Last Posted Date: 2014-07-09

Lead Sponsor: Asan Medical Center

Target Recruit Count: 100

Registration Number: NCT01437202

Locations: 🇨🇦
Princess Margaret Hospital, University of Toronto, Toronto, Canada
🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
🇰🇷
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)

Phase 2

Withdrawn

Conditions: Hepatocellular Carcinoma

Interventions: Other: Radiation therapy
Other: Transarterial chemoembolization

First Posted Date: 2011-09-12

Last Posted Date: 2014-06-26

Lead Sponsor: Asan Medical Center

Registration Number: NCT01432314

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy